1. Home
  2. SEER vs MBOT Comparison

SEER vs MBOT Comparison

Compare SEER & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$2.23

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Logo Microbot Medical Inc.

MBOT

Microbot Medical Inc.

HOLD

Current Price

$1.95

Market Cap

114.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEER
MBOT
Founded
2017
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.3M
114.9M
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
SEER
MBOT
Price
$2.23
$1.95
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.50
AVG Volume (30 Days)
206.8K
779.3K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
9.40
60.27
EPS
N/A
N/A
Revenue
$16,578,000.00
$116,887.00
Revenue This Year
$2.14
N/A
Revenue Next Year
$25.90
$119.77
P/E Ratio
N/A
N/A
Revenue Growth
16.99
N/A
52 Week Low
$1.55
$1.60
52 Week High
$2.41
$4.62

Technical Indicators

Market Signals
Indicator
SEER
MBOT
Relative Strength Index (RSI) 76.79 54.95
Support Level $2.15 $1.65
Resistance Level $2.38 $2.21
Average True Range (ATR) 0.06 0.08
MACD 0.03 0.02
Stochastic Oscillator 86.72 68.71

Price Performance

Historical Comparison
SEER
MBOT

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

Share on Social Networks: